Figure 2.
(A) Schematic for generation of anti-CD22 Fab’ fragments; and (B) Conjugation of anti-CD22 Fab’ to maleimide derivatized LCLA (untargeted long circulating liposomal AD 198).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.